Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-derived Exosomes for Postpartum Endothelial Dysfunction
NCT07183384Phase 2Recruiting
- Sponsor
- Universitas Padjadjaran
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cell exosomes in endothelial dysfunction, sponsored by Universitas Padjadjaran. Started Jul 2024; status: recruiting.
02
Drugs
mesenchymal stem cell exosomes
03
Conditions
endothelial dysfunction
Beyond the preview
Go deeper on NCT07183384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07183384.